celecoxib has been researched along with curcumin in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 16 (53.33) | 24.3611 |
| 2020's | 6 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kishore, N; Kumar, P; Shanker, K; Verma, AK | 1 |
| Kmoníčková, E; Peterková, L; Rimpelová, S; Ruml, T | 1 |
| Lin, YS; Tsao, PN; Wei, SC; Wong, JM; Wu, CH; Wu-Tsai, JJ | 1 |
| Arber, N; Dvory-Sobol, H; Kazanov, D; Lev-Ari, S; Lichtenberg, D; Madar-Shapiro, L; Marian, B; Pinchuk, I; Strier, L | 1 |
| Arber, N; Caspi, D; Elkayam, O; Kazanov, D; Lev-Ari, S; Lichtenberg, D; Strier, L | 1 |
| Arber, N; Ben-Yosef, R; Figer, A; Kazanov, D; Lev-Ari, S; Starr, A; Yona, D; Zinger, H | 1 |
| Arber, N; Giladi, N; Kazanov, D; Lev-Ari, S; Liberman, E; Sagiv, E; Shpitz, B | 1 |
| Lynch, PM | 1 |
| Sasaguri, T; Takahashi-Yanaga, F | 1 |
| Arber, N; Lev-Ari, S; Lichtenberg, D | 1 |
| Brand, RE; Singh, SV; Stan, SD | 1 |
| Maldonado-Rojas, W; Olivero-Verbel, J | 1 |
| Baumeister, P; Boeck, D; Harréus, U; Reiter, M; Schwenk-Zieger, S | 1 |
| Dandekar, P; Gugulothu, D; Kulkarni, A; Patravale, V | 1 |
| Dai, Y; Meng, J; Wan, X; Yan, S; Zhang, Y | 1 |
| Cerella, C; Dicato, M; Diederich, M; Muller, F; Sobolewski, C | 1 |
| Gramignano, G; Macciò, A; Madeddu, C | 1 |
| Annese, T; Chlapanidas, T; Mandracchia, D; Ribatti, D; Ruggieri, S; Trapani, A; Trapani, G; Tripodo, G | 1 |
| Li, Y; Ren, L; Tian, D; Zhu, C | 1 |
| Liu, J; Sun, K; Tian, S; Wang, R; Wang, Y; Yang, X | 1 |
| Bhattarakosol, O; Changtam, C; Patumraj, S; Yoysungnoen, B | 1 |
| Choi, HG; Hong, SS; Kim, JH; Kim, JK; Kim, JO; Kim, SY; Lim, SJ; Thapa, RK | 1 |
| Jiang, B; Jiang, Y; Li, X; Liu, X; Long, Z; Sun, Y; Zhang, L | 1 |
| Bari, E; Catenacci, L; Crivelli, B; Faragò, S; Mocchi, M; Perteghella, S; Prina-Mello, A; Sorrenti, M; Torre, ML; Tripodo, G | 1 |
| Alqahtani, AM; Chandrasekaran, B; Chidambaram, K; Dhanaraj, P; Pino-Figueroa, A; Venkatesan, K | 1 |
| Giacomini, I; Montopoli, M; Quagliariello, V; Ragazzi, E | 1 |
| Bardaweel, SK; Rahal, BA | 1 |
| Hoveizavi, R; Pourreza, N; Zargar, B | 1 |
| Ebrahimi, HA; Esmaeli, S; Khezri, S; Salimi, A | 1 |
| Acuna, UM; Einbond, LS; Figueroa, M; Foster, DA; Jalees, F; Kashiwazaki, R; Kennelly, EJ; Le Gendre, O; Mighty, J | 1 |
5 review(s) available for celecoxib and curcumin
| Article | Year |
|---|---|
Human disorders associated with inflammation and the evolving role of natural products to overcome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Products; Cardiovascular Diseases; Humans; Inflammation; Neoplasms; Skin Diseases | 2019 |
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
Topics: Animals; Antineoplastic Agents; Enzyme Inhibitors; Gene Regulatory Networks; Humans; Neoplasms; Protein Structure, Secondary; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2020 |
GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.
Topics: Animals; Antineoplastic Agents; beta Catenin; Celecoxib; Cell Cycle; Cell Differentiation; Curcumin; Cyclin D1; Dyrk Kinases; Enzyme Activation; Enzyme Activators; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Neoplasms; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Pyrazoles; Retinoids; Signal Transduction; Sulfonamides; Transcription, Genetic; Ubiquitins; Wnt Proteins | 2008 |
Compositions for treatment of cancer and inflammation.
Topics: Apoptosis; Celecoxib; Cell Proliferation; Colorectal Neoplasms; Curcumin; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Synergism; Drug Therapy, Combination; Humans; Osteoarthritis; Pancreatic Neoplasms; Pyrazoles; Sulfonamides | 2008 |
Chemoprevention strategies for pancreatic cancer.
Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta Carotene; Camellia sinensis; Celecoxib; Cell Transformation, Neoplastic; Chemoprevention; Curcumin; Cyclooxygenase 2 Inhibitors; Deoxycytidine; Disease Models, Animal; Down-Regulation; Drug Synergism; Gemcitabine; Humans; Isothiocyanates; Pancreatic Neoplasms; Phototherapy; Pyrazoles; Sulfonamides; Tea; Vitamin D; Vitamin E | 2010 |
25 other study(ies) available for celecoxib and curcumin
| Article | Year |
|---|---|
Comparison of the anti-proliferation and apoptosis-induction activities of sulindac, celecoxib, curcumin, and nifedipine in mismatch repair-deficient cell lines.
Topics: Antineoplastic Agents; Apoptosis; Celecoxib; Cell Cycle; Cell Line, Tumor; Chemoprevention; Colorectal Neoplasms; Curcumin; Endometrial Neoplasms; Female; Humans; Nifedipine; Pyrazoles; Sulfonamides; Sulindac | 2004 |
Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Western; Caco-2 Cells; Celecoxib; Cell Line, Transformed; Cell Line, Tumor; Cell Proliferation; Cell Survival; Curcumin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; HT29 Cells; Humans; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Time Factors | 2005 |
Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Celecoxib; Cell Adhesion; Cell Division; Curcumin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Humans; Lipid Peroxidation; Membrane Proteins; Osteoarthritis, Knee; Pyrazoles; Sulfonamides; Synovial Membrane | 2006 |
Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Blotting, Western; Celecoxib; Cell Line, Tumor; Cell Survival; Curcumin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diet; Drug Synergism; Flow Cytometry; Humans; Pancreatic Neoplasms; Pyrazoles; Sulfonamides | 2005 |
Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Biopsy, Needle; Celecoxib; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Curcumin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Immunohistochemistry; Male; Probability; Pyrazoles; Random Allocation; Rats; Rats, Inbred F344; Sensitivity and Specificity; Sulfonamides | 2006 |
Chemoprevention with special reference to inherited colorectal cancer.
Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Ascorbic Acid; Celecoxib; Chemoprevention; Clinical Trials as Topic; Colorectal Neoplasms; Curcumin; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Eflornithine; Humans; Lactones; Pyrazoles; Sulfonamides; Sulfones; Sulindac; Vitamins | 2008 |
Potential interaction of natural dietary bioactive compounds with COX-2.
Topics: Amino Acid Motifs; Animals; Arachidonic Acid; Catalytic Domain; Celecoxib; Computer Simulation; Curcumin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Fish Oils; Food; Hydrophobic and Hydrophilic Interactions; Lutein; Mice; Models, Molecular; Plant Extracts; Protein Binding; Pyrazoles; Sulfonamides; Thermodynamics | 2011 |
Reduction of DNA damage by curcumin and celecoxib in epithelial cell cultures of the oropharynx after incubation with tobacco smoke condensate.
Topics: Adult; Aged; Case-Control Studies; Celecoxib; Cells, Cultured; Comet Assay; Curcumin; Cyclooxygenase 2 Inhibitors; DNA Damage; Humans; In Situ Hybridization, Fluorescence; Middle Aged; Nicotiana; Oropharynx; Pyrazoles; Smoke; Sulfonamides | 2012 |
pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model.
Topics: Algorithms; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Celecoxib; Colitis, Ulcerative; Colon; Curcumin; Cyclooxygenase 2 Inhibitors; Drug Combinations; Drug Compounding; Drug Synergism; Electrochemistry; Excipients; Freeze Drying; Hydrogen-Ion Concentration; Lipid Peroxidation; Male; Nanoparticles; Particle Size; Peroxidase; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Superoxide Dismutase | 2014 |
Visualization of network target crosstalk optimizes drug synergism in myocardial ischemia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Celecoxib; Cells, Cultured; Curcumin; Cyclooxygenase 2 Inhibitors; Drug Synergism; Drug Therapy, Combination; Humans; Molecular Targeted Therapy; Myocardial Ischemia; Myocytes, Cardiac; Pyrazoles; Rats; Rats, Sprague-Dawley; Silybin; Silymarin; Sulfonamides | 2014 |
Celecoxib prevents curcumin-induced apoptosis in a hematopoietic cancer cell model.
Topics: Apoptosis; Celecoxib; Cell Cycle; Cell Line, Tumor; Curcumin; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Humans; Jurkat Cells; K562 Cells; U937 Cells | 2015 |
Surprising results of a supportive integrated therapy in myelofibrosis.
Topics: Anemia; C-Reactive Protein; Cachexia; Carnitine; Celecoxib; Curcumin; Erythropoietin; Fatigue; Ferritins; Fever; Hepcidins; Humans; Interleukin-6; Iron; Lactoferrin; Male; Middle Aged; Oxidative Stress; Patient Compliance; Primary Myelofibrosis; Quality of Life; Reactive Oxygen Species; Recombinant Proteins; Treatment Outcome; Tumor Necrosis Factor-alpha; Weight Loss | 2015 |
Inulin based micelles loaded with curcumin or celecoxib with effective anti-angiogenic activity.
Topics: Angiogenesis Inhibitors; Animals; Celecoxib; Chick Embryo; Curcumin; Inulin; Micelles | 2016 |
Demethoxycurcumin Preserves Renovascular Function by Downregulating COX-2 Expression in Hypertension.
Topics: Acetylcholine; Aged; Angiotensin II; Animals; Blood Pressure; Celecoxib; Curcuma; Curcumin; Cyclooxygenase 2; Diarylheptanoids; Down-Regulation; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Male; Microscopy, Fluorescence; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Artery; Up-Regulation; Vasoconstriction | 2016 |
Celecoxib-induced inhibition of neurogenesis in fetal frontal cortex is attenuated by curcumin via Wnt/β-catenin pathway.
Topics: Animals; Animals, Newborn; Brain; Celecoxib; Cell Differentiation; Cell Proliferation; Cells, Cultured; Curcumin; Female; Frontal Lobe; Mice; Mice, Inbred C57BL; Neural Stem Cells; Neurogenesis; Neurons; Neurotoxicity Syndromes; Pregnancy; Wnt Signaling Pathway | 2017 |
Combinational Treatment Effect of Tetrahydrocurcumin and Celecoxib on Cervical Cancer Cell-Induced Tumor Growth and Tumor Angiogenesis in Nude Mice.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Celecoxib; Combined Modality Therapy; Curcumin; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Female; Mice; Mice, Nude; Neovascularization, Pathologic; Sulfonamides; Uterine Cervical Neoplasms | 2016 |
Role of zein incorporation on hydrophobic drug-loading capacity and colloidal stability of phospholipid nanoparticles.
Topics: Celecoxib; Colloids; Curcumin; Docetaxel; Drug Carriers; Hydrophobic and Hydrophilic Interactions; Nanoparticles; Paclitaxel; Particle Size; Phospholipids; Surface Properties; Zein | 2018 |
Cell Permeable NBD Peptide-Modified Liposomes by Hyaluronic Acid Coating for the Synergistic Targeted Therapy of Metastatic Inflammatory Breast Cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Celecoxib; Cell Line, Tumor; Cell Movement; Cell-Penetrating Peptides; Curcumin; Drug Liberation; Drug Synergism; Drug Therapy, Combination; Female; Heterografts; Humans; Hyaluronan Receptors; Hyaluronic Acid; Inflammatory Breast Neoplasms; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; NF-kappa B; Treatment Outcome; Tumor Burden | 2019 |
Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis.
Topics: Anti-Inflammatory Agents; Antioxidants; Celecoxib; Cell Survival; Cells, Cultured; Curcumin; Drug Delivery Systems; Drug Liberation; Drug Synergism; Fibroins; Hemolysis; Humans; Nanoparticles; Osteoarthritis; Particle Size; Reactive Oxygen Species | 2019 |
Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Celecoxib; Cell Proliferation; Cell Survival; Curcumin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Female; Humans; Tumor Cells, Cultured | 2021 |
Letter to Editor on the paper entitled "Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer".
Topics: Breast Neoplasms; Celecoxib; Curcumin; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Female; Humans | 2021 |
Implications and Efficacy of Aromatase Inhibitors in Combination and Monotherapy for the Treatment of Lung Cancer.
Topics: Agar; Annexins; Apoptosis; Aromatase; Aromatase Inhibitors; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cisplatin; Curcumin; Humans; Lung Neoplasms; Propidium; Raloxifene Hydrochloride | 2022 |
A nano curcumin-multi-walled carbon nanotube composite as a fluorescence chemosensor for trace determination of celecoxib in serum samples.
Topics: Celecoxib; Curcumin; Microscopy, Electron, Transmission; Nanoparticles; Nanotubes, Carbon | 2022 |
Curcumin-Loaded Chitosan Nanoparticle Preparation and Its Protective Effect on Celecoxib-induced Toxicity in Rat isolated Cardiomyocytes and Mitochondria.
Topics: Animals; Antioxidants; Celecoxib; Chitosan; Curcumin; Drug Carriers; Mitochondria; Myocytes, Cardiac; Nanoparticles; Particle Size; Rats | 2023 |
Garcinia benzophenones inhibit the growth of human colon cancer cells and synergize with sulindac sulfide and turmeric.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Phytogenic; Benzophenones; Butadienes; Celecoxib; Cell Cycle Proteins; Cell Line, Tumor; Curcuma; Dose-Response Relationship, Drug; Drug Synergism; Endoplasmic Reticulum; Enzyme Inhibitors; Epithelial Cells; Garcinia; Gene Expression Regulation, Neoplastic; Heparin; Humans; Inositol 1,4,5-Trisphosphate Receptors; Mechanistic Target of Rapamycin Complex 1; Mitogen-Activated Protein Kinases; Multiprotein Complexes; Nitriles; Phosphoproteins; Plant Extracts; Pyrazoles; Signal Transduction; Structure-Activity Relationship; Sulfonamides; Sulindac; TOR Serine-Threonine Kinases | 2013 |